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Abstract-The sites of synthesis of the chromogranins A and B, and their potential processed 
peptides, were examined by quantitating the levels of chromogranin A and B mRNA in 
various regions of the human brain by Northern blot analysis. Chromogranin A and B mRNA 
expression in the brain is region-specific and confined to grey matter. In situ hybridization 
histochemistry detected chromogranin A and B mRNA in pyramidal neurons of human 
cerebral cortex. Cell-specific expression in subpopulations of cerebrocortical neurons suggest 
that chromogranin A and B gene products may play a role in central neuronal function. 
Introduction 
Chromogranins A and B are two closely-related 
members of a family of abundant acidic glycopro- 
teins found in intracellular secretory organelles and 
distributed widely throughout the diffuse neuroen- 
docrine system and in the CNS (l-l 1). While chro- 
mogranin A (CGA) and chromogranin B (CGB) are 
co-expressed in several neuroendocrine tissues, they 
are also differentially expressed in others, and in sev- 
eral tissues are regulated by different second mes- 
senger and hormonal signals (12- 15). In the human 
adrenal medulla, CGA and CGB are similarly abun- 
dant and co-stored in all cells ( 16, 17). Sympathetic 
neurons also contain both CGA and CGB ( 18-20). 
In the pituitary gland, CGA and CGB are co-local- 
ized in somatotrophs and thyrotrophs, yet only CGA 
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is expressed in gonadotrophs, and only CGB in 
prolactinomas (21-26). CGA and CGB immuno- 
reactivity exhibits an uneven distribution in the 
rat and bovine brain with cerebral cortical areas 
enriched (2-4 times) for CGA and cerebellum 
enriched (approximately 10 times) for CGB ( 15,27. 
28). In addition, the expression of CGA and CGB 
immunoreactivity in brain tissue may be restricted 
to certain neuronal subsets (29-33). 
The localization of sites of synthesis of CGA and 
CGB in the brain may be important for determining 
the roles played by these two proteins in CNS func- 
tion. Determining the differential location of CGA- 
and CGB-producing cells in the CNS is confounded 
at the protein level by two factors. First, CGA and 
CGB are presumably synthesized in neuronal cell 
bodies, packaged in storage organelles and trans- 
ported to nerve endings. Processing CGA and CGB 
into polypeptide breakdown products may occur en 
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route to the nerve ending. Thus, the presence of CGA 
and CGB immunoreactivity in a given brain region 
may indicate the presence of CG in cell bodies, fibers 
of passage and nerve terminals. Secondly, deter- 
mining the distribution of CGA and CGB by 
immunochemical methods is complicated by the 
presence of multiple protolitically processed pep- 
tide fragments of each protein for which a given 
antibody or antiserum may have differential cross- 
reactivity (22,34-40). Studies of the distribution of 
CGA and CGB mRNA may therefore be the most 
unambiguous means of determining the location of 
cells which express CGA, CGB and their processed 
peptide products in the brain (5, 15, 41,42, 43). In 
the present report, an analysis of the regional expres- 
sion of CGA and CGB mRNA gene products in the 
human CNS is presented. 
Material and Methods 
Human tissue was removed from cadavers 3.5 to 
24 h postmortem, weighed, placed in aluminum 
foil, frozen in liquid nitrogen and stored at -70°C. 
Adjacent samples were fixed in Bouin’s solution, 
embedded in paraffin and examinedmicroscopically 
to verify their location and to evaluate the presence 
of any abnormalities. The brain samples were mostly 
neuron rich cerebral cortex and telencephalic nuclei, 
but associated white matter was also present. Cer- 
ebral grey matter was separated from white matter 
in one case. The tissues were grossly and micro- 
scopically normal and the patients had no evidence 
of neurological disorders. 
The purification of mRNA was by the guani- 
dinium isothiocyanate/cesium trifluoroacetic acid 
method followed by oligo-dT cellulose chromatog- 
raphy (44, 45). Approximately 10 ~18 of poly (A)* 
RNA per lane were dissolved in twenty microliters 
of a solution containing: 2.2 M formaldehyde/ 
50% formamide/ mM MOPS/5 mM sodium 
acetate/l mM EDTA, pH 7.0/0.025% bromophenol 
blue and denatured at 60°C for 10 min. The RNA 
was electrophoresed in 1.0% agarose gels con- 
taining 2.2 M formaldehyde120 mM MOPS/S mM 
sodium acetate/l mM EDTA. After transfer to 
GeneScreen (New England Nuclear) or Nytran (S & 
S) and crosslinked by UV irradiation (120,000 p.l), 
the RNA blots were prehybridized (12 h) and then 
hybridized with cDNA or oligonucleotide probes 
(10” cpmml) in a buffer containing: 4 x SSC (600 
mM NaCl/60 mM sodium citrate, pH 7.0)/50% 
formamide/l x Denhardts (0.5% ficoll. 0.5% poly- 
vinylpyrrolidone, 0.5% bovine serum albumin)/ 
200 pg/ml tRNA/250 @ml salmon sperm DNA 
(sheared and heat denatured) for 18 h at 42°C. The 
filters were washed in 0.2 x SSC/O. 1% NaDodS04 
at 45°C (oligodeoxyribonucleotides) or 55°C (CGA 
cDNA fragment) and exposed to x-ray film at 
-70°C. 
In situ hybridization histochemistry was per- 
formed as described previously (26). Briefly, frozen 
post-mortem human brain sections (8 pm thick) from 
the cerebral cortex were thaw-mounted onto 3- 
aminopropylmethoxy silane-coated glass slides 
(Aldrich, Milwaukee, Wisconsin, USA). Warmed 
(24°C) sections were fixed in 4% parafotmaldehyde 
and soaked in 0.25% acetic anhydride/O.l M tri- 
ethanolamine hydrochloride/0.9% NaCl. Following 
dehydration through a series of ethanol solutions the 
tissues were delipidated in chloroform and re- 
hydrated in 95% ethanol and air-dried. Hybridiza- 
tion was performed in buffer containing: 4 x SSC 
(600 mM NaC1/60 mM sodium citrate, pH 7.0)/ 
50% formamide/l x Denhardts (0.5% ficoll, 0.5% 
polyvinylpyrrolidone, 0.5% bovine serum albu- 
min)/l mg/ml DTT/250 pg/ml tRNA/SOO pg/ml 
salmon sperm DNA (sheared and heat denatured) 
and ?S-labeled 24-mer (CGA) or 39-mer (CGB) 
oligodeoxyribonucleotide probes (600000 cpm) for 
16 h at 44°C in a humid chamber. Slides were 
washed in 0.5 x SSC/O.l% NaDodSOl at 44”C, 
dehydrated in 95% and 100% ethanol with 0.3 M 
ammonium acetate, and air dried. Autoradiography 
was carried out by dipping in Kodak NTB2 emul- 
sion diluted 1: 1 with distilled water containing 0.3 
M ammonium acetate. The slides were allowed to 
air dry for 1 h and then subsequently developed for 
3 min in Kodak D-19 developer, washed in water for 
1 min and fixed for 5 min in Kodak Fixer. After 
washing for 1 h they were stained with hematoxylin 
and eosin, and coverslipped. 
Oligodeoxyribonucleotides complementary to the 
coding regions of human CGA (5 1 -mer: cDNA base 
numbers 137- 187; 24-mer cDNA base numbers 966- 
989) (46), CGB (39-mer: cDNA base numbers 3-42) 
(2) and @actin (37-mer: cDNA base numbers: 1466- 
1502) were synthesized on an Applied Biosystems 
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380A DNA synthesizer and purified by electro- 
phoresis in a preparative denaturing acrylamide gel. 
The oligonucleotide probes (5 pmol) were labeled 
to a specific activity of 3500 Wmmol, using ter- 
minal deoxynucleotidyl transferase (100 units; 
Bethesda Research Laboratories) and (a-32P)-dATP 
( 1 pM; 3000 Ci/mmol; New England Nuclear) or 
(?)thio-dATP (1 pM; 1300 Ci/mmol; Amersham). 
A cDNA fragment complementary to CGA (cDNA 
base numbers 1004- I 246) was prepared as described 
previously (26). The cDNA probe was nick-trans- 
lated to a specific activity of lox cpm/pg using (a- 
“P)-dATP and Klenow polymerase. The RNA blots 
were sequentially hybridized to CGA, CGB and p- 
actin probes, and stripped ofthe preceding probe with 
95% formamide/l mM EDTA/lO mM tris; pH 8.0 
for 30 min at 60°C followed by a thorough wash 
in 1 x SSPE (180 mM NaW2 mM EDTA/lO mM 
NaHzPOJ; pH 7.4). 
Results and Discussion 
The regional distribution of CGA and CGB mRNA 
transcripts in human brain by Northern blotting is 
shown in Figure 1. Single mRNA species of 2.3 kb 
and 2.5 kb hybridized to CGA and CGB probes, 
respectively. CGA and CGB mRNA exhibited an 
uneven distribution with cerebral cortical areas 
(frontal lobe, occipital pole, parietal cortex and 
temporal tip) and dorsal root ganglia displaying 
greater levels than that observed in the thalamus 
(pulvinar), basal ganglia (caudate, putamen), and 
spinal cord. CGB mRNA was as abundant in the 
hippocampus (dentate) as cerebral cortex. A similar 
enrichment of CGA mRNA in cerebral cortex versus 
hippocampus has been observed in rat brain (42). In 
addition, CGA mRNA levels are enriched in cerebral 
cortex and caudate nucleus when compared to 
hippocampus and cerebellum in bovine brain 
(unpublished data). The greatest regional difference 
in expression of CGA and CGB mRNA in human 
brain was in the cerebellum (vermis) where no 
visualization of CGA mRNA was observed even after 
overexposure of the film. The mRNA obtained from 
human cerebellum was however, partly degraded. 
Yet, cerebellum was the richest source for CGB when 
the hybridization signals are compared to p-actin 
(Table). CGB immunoreactivity is highest in rat 
Fig. 1 Northern hybridization analysis of mRNA from human 
brain regions and peripheral tissues. Approximately IO ug ofpoly 
(A)’ RNA was prepared from each tissue sample: Hip, hip- 
pocampus; Occ, occipital pole; Thm, thalamus; Cbl, cerebellum; 
Frm, frontal lobe; Par, parietal cortex; Tern, temporal tip; C’au, 
caudate nucleus; Spl, spleen; Put, putamen: Spi, spinal cord; Adr, 
adrenal gland; Sgn, sympathetic ganglion; Cpx, choroid plexus; 
Col. colon. The RNA blots of case 1 (upper) and case 2 (lower) 
were successively hybridized, stripped and reprobed with cDNA 
(chromogranin A) or oligonucleotide probes derived from 
chromogranin A (5 1 -mer), chromogranin B (39-mer) and b-actin 
(37-mer). Exposure time was approximately 4 days for the chro- 
mogranins A and B probes and 45 min for the b-actin probe at 
-70°C with intensifying screens. The size of the chromo- 
granins A and B and S-actin mRNAs (kb) are indicated on the 
right. 
cerebellum particularily in Purkinje neurons ( 15.29). 
CGB mRNA, however, has a more even distribution 
in rat brain which may be indicative of species 
variation (41). Low amounts of CGA and CGB 
mRNA were also detected in the colon while both the 
spleen and choroid plexus were negative for both 
mRNA species. CGA and CGB mRNA levels in 
human adrenal medulla are considerably greater than 
that observed in cerebral cortex based upon relative 
242 UEUROPEP’I’IDES 
Table Chromogranin A and chromogranin B mRNA 
expression in various human brain regions. The ratio of 
chromogranin A and chromogranin B mRNA to P-a&in 
mRNA in brain areas from case 1 and case 2 was deter- 
mined by spectrophotometric analysis of hybridization 
signals on X-ray films. The values are normalized to 
levels observed in the frontal cortex for each case. 
ND = not detectable. 
Chromogranin A Chromogranin B 
Case I 
Frontal cortex 1 .oo 1.00 
Parietal cortex 1.37 0.84 
Occipital cortex 1.25 0.87 
Temporal cortex 0.68 0.49 
Hippocampus 0.41 1.20 
Cerebellum ND 2.33 
Thalamus 0.34 0.52 s 
Caudate 0.29 0.39 
Citsr 2 
Frontal cortex 1.00 1.00 
Cerebellum ND 3.67 
Sympathetic ganglion 0.56 I .69 
Fig. 3 In situ hybridization histochemistry ofchromogranins A 
and B mRNA-containing cells in sections of human cerebral cor- 
expression of p-actin mRNA (Fig. 2). Differences tex. Large and small pyramidal-shaped neuronal cell bodies were 
in the abundance of CGA and CGB mRNAs in the positive for both chromogranins A and B mRNA (upper panel) 
adrenal gland of case 2 (Fig. 1) and case 3 (Fig. 2) 
while similiar cells were unlabeled in the presence of IOO-fold 
excess of the respective unlabeled probe (lower panel ). 
may be due to differing amounts of adrenal cortical 
tissue present. A comparison ofpoly (A)’ RNA from 
human cerebral grey and white matter indicated an 
enrichment of both CGA and CGB mRNAs in neu- 
ron-enriched cortex rather than glia-enriched white 
matter (Fig. 2). In situ hybridization histochemistry 
revealed the presence of silver grains over pyrami- 
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Fig. 2 Northern hybridization analysis of mRNA from human 
cerebral cortical grey matter, white matter and adrenal medulla. 
Approximately 5 pg of poly (A)’ RNA was prepared from each 
tissue sample and the RNA blots were successively hybridized, 
stripped and reprobed with oligonucleotide probes derived from 
chromogranin A (24-mer), chromogranin B (39-mer) and p-actin 
(37-mer). Blot hybdridization and washing stringency for CGA 
and CGB signals were similar to those used for in situ experi- 
ments. 
da1 neuron cell bodies of human cerebral cortex for 
both CGA and CGB probes (Fig. 3). Specificity of 
the in situ signal was assessed by hybridization in 
the present of a lOO-fold excess of unlabeled probes. 
In addition, the specificity of the respective oligo- 
nucleotides for their appropriate mRNA species 
was determined by Northern analysis (Fig. 2). 
Recently, immunocytochemical detection of CGA- 
like material in large and small pyramidal neur- 
ons of the human cerebral cortex has been demon- 
strated (3 1). CGB mRNA has also been detected in 
pyramidal neurons of the cerebral cortex in rat (4 1). 
The pyramidal neurons of the cerebral cortex 
project extensive collaterals locally and to other 
cerebrocortical regions and send projection fibers 
to a variety of structures including the thalamic 
nuclei, the basal ganglia, many parts of the brain 
stem, and the spinal cord (47). The presence of 
CGA and CGB immunoreactivity in the cerebral 
cortex and these subcortical structures in several 
species (15, 20, 28, 30-33) may be contained, in 
part, in cerebral cortical pyramidal nerve endings. 
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We have examined the distribution of CGA and 
CGB mRNA in various human brain regions and in 
individual cells of cerebral cortex. The uneven dis- 
tribution of CGA and CGB mRNA in the brain sug- 
gests that expression is restricted to specific neuronal 
subsets with the central nervous system. The expres- 
sion of CGA and CGB mRNA in predominantly 
human cerebral grey matter, and particularly in pyra- 
midal neurons of the cerebral cortex, supports a role 
for their gene products in central neuronal function. 
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